Literature DB >> 24922687

Excellent prognosis of lepidic-predominant lung adenocarcinoma: low incidence of lymphatic vessel invasion as a key factor.

Kunio Araki1, Yoshiteru Kidokoro2, Keiko Hosoya2, Makoto Wakahara2, Yuki Matsuoka2, Yuzo Takagi2, Tomohiro Haruki2, Ken Miwa2, Yuji Taniguchi2, Satoshi Horie3, Hiroshige Nakamura2.   

Abstract

AIM: To clarify the prognostic value of predominant histological subtypes for small-sized lung adenocarcinoma.
MATERIALS AND METHODS: Sixty-four specimens of resected invasive lung adenocarcinoma less than 20 mm in diameter with no lymph node metastasis were studied. These specimens were microscopically classified into predominant histological subtypes (21 lepidic, 16 acinar, 24 papillary, and three solid) according to the International association for the study of lung cancer/American thoracic society/European respiratory society adenocarcinoma classification. The relationships between tumor relapse and predominant histological subtypes were statistically analyzed. In addition the relationships between several pathological factors and predominant histological subtypes were statistically assessed.
RESULTS: Kaplan-Meier relapse-free curves showed a five-year relapse-free rate of 100% in 64 patients with lepidic-predominant adenocarcinoma, compared with a rate of 73.7% (p=0.035 by log rank test) in patients with non-lepidic-predominant adenocarcinoma (papillary, acinar, and solid). The only statistically significant pathological factor between lepidic-predominant and non-lepidic-predominant histological subtypes was lymphatic vessel invasion as assessed by logistic regression analysis.
CONCLUSION: In small-sized lung adenocarcinoma, lepidic-predominant histological subtype is the best prognostic factor, and a low incidence of lymphatic vessel invasion in the histological subtype is a key factor for an excellent prognosis. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Prognostic factor; histological subtype; lepidic-predominant; lymphatic vessel invasion; small lung adenocarcinoma

Mesh:

Year:  2014        PMID: 24922687

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

Review 1.  Clinical impact of the new IASLC/ATS/ERS lung adenocarcinoma classification for chest surgeons.

Authors:  Haruhiko Nakamura; Masayuki Takagi
Journal:  Surg Today       Date:  2014-11-23       Impact factor: 2.549

2.  Heterogeneity of PD-L1 expression between invasive and lepidic components of lung adenocarcinomas.

Authors:  Antonious Hazim; Neil Majithia; Stephen J Murphy; Dennis Wigle; Marie-Christine Aubry; Aaron S Mansfield
Journal:  Cancer Immunol Immunother       Date:  2021-02-18       Impact factor: 6.968

3.  Preoperative serum carcinoembryonic antigen levels are associated with histologic subtype, EGFR mutations, and ALK fusion in patients with completely resected lung adenocarcinoma.

Authors:  Zeng Wang; Shifeng Yang; Hongyang Lu
Journal:  Onco Targets Ther       Date:  2017-07-07       Impact factor: 4.147

4.  Prognostic role of TPL2 in early‑stage non‑small cell lung cancer.

Authors:  Laura Boldrini; Mirella Giordano; Adele Servadio; Cristina Niccoli; Pietro Bertoglio; Marco Lucchi; Franca Melfi; Alfredo Mussi; Gabriella Fontanini
Journal:  Mol Med Rep       Date:  2017-04-03       Impact factor: 2.952

5.  Signal transducer and activator of transcription 3 overexpression promotes lymph node micrometastasis in early-stage non-small cell lung cancer.

Authors:  Yang Yu; Qian Zhao; Xiao-Peng He; Zhou Wang; Xiang-Yan Liu; Zhi-Ping Zhang
Journal:  Thorac Cancer       Date:  2018-03-25       Impact factor: 3.500

6.  Convolutional neural networks can accurately distinguish four histologic growth patterns of lung adenocarcinoma in digital slides.

Authors:  Arkadiusz Gertych; Zaneta Swiderska-Chadaj; Zhaoxuan Ma; Nathan Ing; Tomasz Markiewicz; Szczepan Cierniak; Hootan Salemi; Samuel Guzman; Ann E Walts; Beatrice S Knudsen
Journal:  Sci Rep       Date:  2019-02-06       Impact factor: 4.379

7.  Risk factors associated with an increase in the size of ground-glass lung nodules on chest computed tomography.

Authors:  Hee-Young Yoon; Ji-Yun Bae; Yookyung Kim; Sung Shin Shim; Sojung Park; So-Young Park; Soo Jung Kim; Yon Ju Ryu; Jung Hyun Chang; Jin Hwa Lee
Journal:  Thorac Cancer       Date:  2019-06-02       Impact factor: 3.500

8.  Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis.

Authors:  Yue Zhao; Rui Wang; Xuxia Shen; Yunjian Pan; Chao Cheng; Yuan Li; Lei Shen; Yang Zhang; Hang Li; Difan Zheng; Ting Ye; Shanbo Zheng; Yihua Sun; Haiquan Chen
Journal:  Ann Surg Oncol       Date:  2016-02-02       Impact factor: 5.344

9.  Clinical Significance of Complex Glandular Patterns in Lung Adenocarcinoma: Clinicopathologic and Molecular Study in a Large Series of Cases.

Authors:  Muyu Kuang; Xuxia Shen; Chongze Yuan; Haichuan Hu; Yang Zhang; Yunjian Pan; Chao Cheng; Difan Zheng; Lei Cheng; Yue Zhao; Xiaoting Tao; Yuan Li; Haiquan Chen; Yihua Sun
Journal:  Am J Clin Pathol       Date:  2018-05-31       Impact factor: 2.493

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.